Published in Hum Reprod Update on August 05, 2004
Association Between Testosterone Supplementation Therapy and Thrombotic Events in Elderly Men. Urology (2015) 1.99
Regulation of the steroidogenic acute regulatory protein gene expression: present and future perspectives. Mol Hum Reprod (2009) 1.49
Advances in male contraception. Endocr Rev (2008) 1.39
Hypogonadism in the aging male diagnosis, potential benefits, and risks of testosterone replacement therapy. Int J Endocrinol (2012) 1.18
Negative association between testosterone concentration and inflammatory markers in young men: a nested cross-sectional study. PLoS One (2013) 1.01
Testosterone for the aging male; current evidence and recommended practice. Clin Interv Aging (2008) 0.98
Reexamination of pharmacokinetics of oral testosterone undecanoate in hypogonadal men with a new self-emulsifying formulation. J Androl (2011) 0.96
Testosterone replacement and bone mineral density in male pituitary tumor patients. Endocrinol Metab (Seoul) (2014) 0.84
The rational use of pituitary stimulation tests. Dtsch Arztebl Int (2010) 0.83
Directed mouse embryonic stem cells into leydig-like cells rescue testosterone-deficient male rats in vivo. Stem Cells Dev (2014) 0.82
Effect of long-acting testosterone undecanoate treatment on quality of life in men with testosterone deficiency syndrome: a double blind randomized controlled trial. Asian J Androl (2012) 0.82
Effects of Eurycoma longifolia on Testosterone Level and Bone Structure in an Aged Orchidectomised Rat Model. Evid Based Complement Alternat Med (2012) 0.80
The prevalence of hypogonadism in diabetic men in Isfahan Endocrine and Metabolism Research Center, Isfahan, Iran. J Res Med Sci (2012) 0.79
Testosterone and phosphodiesterase type-5 inhibitors: new strategy for preventing endothelial damage in internal and sexual medicine? Ther Adv Urol (2009) 0.78
Androgen Deficiency and Erectile Dysfunction in Patients with Type 2 Diabetes. Clin Med Insights Endocrinol Diabetes (2015) 0.77
Androgens and male aging: Current evidence of safety and efficacy. Asian J Androl (2010) 0.77
In vitro and in vivo evaluation of a novel testosterone transdermal delivery system (TTDS) using palm oil base. Iran J Basic Med Sci (2015) 0.75
Pharmacokinetics and drying time of testosterone 2% gel in men with hypogonadism: a multicenter, open-label, single-arm trial. Int J Impot Res (2014) 0.75
Study of Sex Hormone-binding Globulin Gene Polymorphism and Risk of Type 2 Diabetes Mellitus in Egyptian Men. West Indian Med J (2015) 0.75
Retracted The Effect of Testosterone on Men With Andropause. Iran Red Crescent Med J (2015) 0.75
Hypogonadism: Easy to define, hard to diagnose, and controversial to treat. Can Urol Assoc J (2015) 0.75
Pharmacology of testosterone replacement therapy preparations. Transl Androl Urol (2016) 0.75
Effect of short-term androgen deficiency on bladder contractility and urothelial mediator release. Naunyn Schmiedebergs Arch Pharmacol (2017) 0.75
Transplanted human p75-positive stem Leydig cells replace disrupted Leydig cells for testosterone production. Cell Death Dis (2017) 0.75
Assessment of Hypogonadism in Men With Type 2 Diabetes: A Cross-Sectional Study From Saudi Arabia. Clin Med Insights Endocrinol Diabetes (2017) 0.75
Human Y chromosome azoospermia factors (AZF) mapped to different subregions in Yq11. Hum Mol Genet (1996) 3.78
Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nat Genet (1998) 3.42
Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms. Eur Heart J (2000) 2.85
Lifespan and testosterone. Nature (1993) 2.84
Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab (2008) 2.70
Investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male (2005) 2.60
Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol (2006) 2.46
Thresholds of focal cerebral ischemia in awake monkeys. J Neurosurg (1981) 2.23
Trace metals as biomarkers for eumelanin pigment in the fossil record. Science (2011) 2.13
Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic mice. J Exp Med (1998) 2.08
Creatine kinase activity in human spermatozoa and seminal plasma lacks predictive value for male fertility in in vitro fertilization. Fertil Steril (1998) 1.98
The Menopause Rating Scale (MRS): reliability of scores of menopausal complaints. Climacteric (2000) 1.91
Characterization of the membrane protein component of the lactose transport system of Escherichia coli. J Biol Chem (1969) 1.81
Late-onset hypogonadism and mortality in aging men. J Clin Endocrinol Metab (2013) 1.77
Endogenous cannabinoid system as a modulator of food intake. Int J Obes Relat Metab Disord (2003) 1.74
A spontaneous and severe hyperstimulation of the ovaries revealing a gonadotroph adenoma. J Clin Endocrinol Metab (1998) 1.72
Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: A randomized, double-blind, placebo-controlled study. Circulation (2000) 1.71
Impacts of soil faunal community composition on model grassland ecosystems. Science (2002) 1.70
Epidemiology of periodontal status in dentate adults in France, 2002-2003. J Periodontal Res (2007) 1.66
External quality control in the andrology laboratory: an experimental multicenter trial. Fertil Steril (1990) 1.65
The Menopause Rating Scale (MRS): comparison with Kupperman index and quality-of-life scale SF-36. Climacteric (2000) 1.62
Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. J Clin Endocrinol Metab (2000) 1.60
Chronic widespread pain is associated with slower cognitive processing speed in middle-aged and older European men. Pain (2010) 1.58
Androgens, insulin resistance and vascular disease in men. Clin Endocrinol (Oxf) (2005) 1.58
Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations. Eur J Endocrinol (2008) 1.55
Smoking and hormones in health and endocrine disorders. Eur J Endocrinol (2005) 1.55
Cryopreservation of semen from adolescent patients with malignancies. Med Pediatr Oncol (1996) 1.53
Why delay the obvious need for milder forms of ovarian stimulation? Hum Reprod (1997) 1.50
Brief report: melatonin-related hypogonadotropic hypogonadism. N Engl J Med (1992) 1.48
erythro-9-[3-(2-Hydroxynonyl)]adenine is an inhibitor of sperm motility that blocks dynein ATPase and protein carboxylmethylase activities. Proc Natl Acad Sci U S A (1981) 1.48
Recombinant human follicle-stimulating hormone and human chorionic gonadotropin for induction of spermatogenesis in a hypogonadotropic male. Fertil Steril (1995) 1.45
Minimal ovarian stimulation for IVF: appraisal of potential benefits and drawbacks. Hum Reprod (1999) 1.45
Junior doctors and the full shift rota--psychological and hormonal changes: a comparative cross-sectional study. Clin Med (2006) 1.40
[The Kallmann syndrome. Its pathophysiology and clinical picture]. Dtsch Med Wochenschr (1994) 1.39
The release of leptin and its effect on hormone release from human pituitary adenomas. Clin Endocrinol (Oxf) (2001) 1.39
Tooth extraction decision model in periodontitis patients. Clin Oral Implants Res (2010) 1.38
Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin). Fertil Steril (2000) 1.35
PILRalpha, a novel immunoreceptor tyrosine-based inhibitory motif-bearing protein, recruits SHP-1 upon tyrosine phosphorylation and is paired with the truncated counterpart PILRbeta. J Biol Chem (2000) 1.32
Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. J Androl (2008) 1.31
The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes. Eur J Endocrinol (2007) 1.30
Gender differences in the vasomotor effects of different steroid hormones in rat pulmonary and coronary arteries. Horm Metab Res (2001) 1.28
Scheduled administration of a gonadotrophin-releasing hormone antagonist (Cetrorelix) on day 8 of in-vitro fertilization cycles: a pilot study. Hum Reprod (1995) 1.26
Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. J Androl (2006) 1.26
Sex pheromones in snakes. Science (1989) 1.26
Hyperprolactinaemia. BMJ (1988) 1.26
Immunomodulatory effects of IL-12 on allergic lung inflammation depend on timing of doses. J Immunol (1996) 1.25
Purification and characterization of a protein tyrosine phosphatase containing SH2 domains. J Biol Chem (1993) 1.25
Regulation of the human menstrual cycle. Front Neuroendocrinol (1998) 1.23
Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life. Heart (2004) 1.22
ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males. Int J Impot Res (2008) 1.22
High prevalence of biochemical acromegaly in primary care patients with elevated IGF-1 levels. Clin Endocrinol (Oxf) (2008) 1.22
Defining mechanisms of action of interleukin-11 on the progression of radiation-induced oral mucositis in hamsters. Oral Oncol (2000) 1.22
A novel mutation in DAX1 causes delayed-onset adrenal insufficiency and incomplete hypogonadotropic hypogonadism. J Clin Invest (2000) 1.19
Age-associated changes in hypothalamic-pituitary-testicular function in middle-aged and older men are modified by weight change and lifestyle factors: longitudinal results from the European Male Ageing Study. Eur J Endocrinol (2013) 1.17
Use of immunocytochemistry of progesterone and estrogen receptors for endometrial dating. J Clin Endocrinol Metab (1988) 1.16
Comparison of octreotide acetate LAR and lanreotide SR in patients with acromegaly. Clin Endocrinol (Oxf) (2000) 1.15
Conditional mouse mutants highlight mechanisms of corticotropin-releasing hormone effects on stress-coping behavior. Mol Psychiatry (2008) 1.15
Dynein ATPase is inhibited selectively in vitro by erythro-9-[3-2-(hydroxynonyl)]adenine. Biochem Biophys Res Commun (1982) 1.14
Immobilisation hypercalcaemia in adults and treatment with clodronate. Br Med J (Clin Res Ed) (1984) 1.14
Testosterone as a protective factor against atherosclerosis--immunomodulation and influence upon plaque development and stability. J Endocrinol (2003) 1.12
Exacerbation of diarrhoea and pain in patients treated with 5-aminosalicylic acid for ulcerative colitis. Lancet (1984) 1.12
Blunted corticotropin and normal cortisol response to human corticotropin-releasing factor in depression. N Engl J Med (1984) 1.12
The use of GnRH antagonists in ovarian stimulation. Hum Reprod Update (2002) 1.11
Testosterone treatment for men with chronic heart failure. Heart (2004) 1.09
Heteropteran chemical repellents identified in the citrus odor of a seabird (crested auklet: Aethia cristatella): evolutionary convergence in chemical ecology. Naturwissenschaften (2001) 1.08
Species differences in the expression and distribution of the neuropeptide Y Y1, Y2, Y4, and Y5 receptors in rodents, guinea pig, and primates brains. J Comp Neurol (1998) 1.08
Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression. Implications for pathophysiology of DST nonsuppression. Biol Psychiatry (1987) 1.08
Expression of epidermal growth factor receptor in neoplastic pituitary cells: evidence for a role in corticotropinoma cells. J Endocrinol (2004) 1.08
Prevalence of anterior pituitary insufficiency 3 and 12 months after traumatic brain injury. Eur J Endocrinol (2006) 1.07
Androgen receptor CAG repeat polymorphism is associated with serum testosterone levels, obesity and serum leptin in men with type 2 diabetes. Eur J Endocrinol (2008) 1.06
Serum FSH and testicular morphology in male infertility. Clin Endocrinol (Oxf) (1994) 1.05
Defensive adaptations of eggs and adults ofGastrophysa cyanea (Coleoptera: Chrysomelidae). J Chem Ecol (1982) 1.05
Retinoic acid prevents experimental Cushing syndrome. J Clin Invest (2001) 1.05
Quality of life in acromegalic patients during long-term somatostatin analog treatment with and without pegvisomant. J Clin Endocrinol Metab (2008) 1.05
A fatal cytokine-induced systemic inflammatory response reveals a critical role for NK cells. J Immunol (1999) 1.05
Erectile dysfunction is associated with low bioactive testosterone levels and visceral adiposity in men with type 2 diabetes. Int J Androl (2007) 1.05
Unmet needs in the diagnosis and treatment of dyslipidemia in the primary care setting in Germany. Atherosclerosis (2006) 1.05
Interleukin involvement in anterior pituitary cell growth regulation: effects of IL-2 and IL-6. Endocrinology (1993) 1.05
Screening for deletions of the Y chromosome involving the DAZ (Deleted in AZoospermia) gene in azoospermia and severe oligozoospermia. Fertil Steril (1997) 1.05
Investigation, treatment and monitoring of late-onset hypogonadism in males. ISA, ISSAM, and EAU recommendations. Eur Urol (2005) 1.04
The LHRH antagonist cetrorelix: a review. Hum Reprod Update (2000) 1.04
New methylcyclopentanoid terpenes from the larval defensive secretion of a chrysomelid beetle (Plagiodera versicolora). Proc Natl Acad Sci U S A (1977) 1.03
Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. Int J Androl (2005) 1.03
Prevalence of tooth wear on buccal and lingual surfaces and possible risk factors in young European adults. J Dent (2013) 1.02
The expression of the antiproliferative gene ZAC is lost or highly reduced in nonfunctioning pituitary adenomas. Cancer Res (2000) 1.02
Time to revolutionize ovarian stimulation. Hum Reprod (1996) 1.01
Chromosome abnormalities in 447 couples undergoing intracytoplasmic sperm injection--prevalence, types, sex distribution and reproductive relevance. Hum Reprod (1998) 1.01
Positive effect of overexpressed protein-tyrosine phosphatase PTP1C on mitogen-activated signaling in 293 cells. J Biol Chem (1996) 1.01
Nature and bioactivity of gonadotropin-releasing hormone (GnRH) secreted during the GnRH surge. Endocrinology (1995) 1.00
Bacteria, viruses, and parasites in an intermittent stream protected from and exposed to pasturing cattle: prevalence, densities, and quantitative microbial risk assessment. Water Res (2013) 0.99
Diabetes mellitus following pentamidine-induced hypoglycemia in humans. Diabetes (1982) 0.99
Raising sperm from the dead. J Androl (1996) 0.99